| PCSK9 induces a pro-inflammatory response in macrophages C Ricci, M Ruscica, M Camera, L Rossetti, C Macchi, A Colciago, I Zanotti, ... Scientific reports 8 (1), 2267, 2018 | 230 | 2018 |
| Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: New therapeutic approaches for the treatment of atherogenic dyslipidemia M Ruscica, F Zimetti, MP Adorni, CR Sirtori, MG Lupo, N Ferri Pharmacological research 153, 104653, 2020 | 80 | 2020 |
| Naturally occurring PCSK9 inhibitors MP Adorni, F Zimetti, MG Lupo, M Ruscica, N Ferri Nutrients 12 (5), 1440, 2020 | 75 | 2020 |
| Angiopoietin-like 3 (ANGPTL3) and atherosclerosis: lipid and non-lipid related effects MG Lupo, N Ferri Journal of cardiovascular development and disease 5 (3), 39, 2018 | 58 | 2018 |
| Tuning the cytotoxicity of ruthenium (II) para-cymene complexes by mono-substitution at a triphenylphosphine/phenoxydiphenylphosphine ligand L Biancalana, S Zacchini, N Ferri, MG Lupo, G Pampaloni, F Marchetti Dalton Transactions 46 (47), 16589-16604, 2017 | 56 | 2017 |
| Sex-specific predictors of PCSK9 levels in a European population: the IMPROVE study N Ferri, M Ruscica, D Coggi, A Bonomi, M Amato, B Frigerio, D Sansaro, ... Atherosclerosis 309, 39-46, 2020 | 53 | 2020 |
| Exploring the Anticancer Potential of Diiron Bis-cyclopentadienyl Complexes with Bridging Hydrocarbyl Ligands: Behavior in Aqueous Media and In Vitro Cytotoxicity G Agonigi, L Biancalana, MG Lupo, M Montopoli, N Ferri, S Zacchini, ... Organometallics 39 (5), 645-657, 2020 | 45 | 2020 |
| Long-term exposure to air pollution raises circulating levels of proprotein convertase subtilisin/kexin type 9 in obese individuals C Macchi, N Ferri, C Favero, L Cantone, L Vigna, AC Pesatori, MG Lupo, ... European Journal of Preventive Cardiology 26 (6), 578-588, 2019 | 45 | 2019 |
| Current evidence and future perspectives on pharmacological treatment of calcific aortic valve stenosis M Donato, N Ferri, MG Lupo, E Faggin, M Rattazzi International journal of molecular sciences 21 (21), 8263, 2020 | 44 | 2020 |
| Leptin, resistin, and proprotein convertase subtilisin/kexin type 9: the role of STAT3 C Macchi, MF Greco, M Botta, P Sperandeo, P Dongiovanni, L Valenti, ... The American journal of pathology 190 (11), 2226-2236, 2020 | 35 | 2020 |
| Mitochondrial depletion of glutaredoxin 2 induces metabolic dysfunction-associated fatty liver disease in mice V Scalcon, A Folda, MG Lupo, F Tonolo, N Pei, I Battisti, N Ferri, ... Redox Biology 51, 102277, 2022 | 29 | 2022 |
| Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms and susceptibility to recurrent pregnancy loss D Dell'Edera, A L'episcopia, F Simone, MG Lupo, AA Epifania, A Allegretti Biomedical Reports 8 (2), 172-175, 2018 | 29 | 2018 |
| The influence of D‑chiro‑inositol and D‑myo‑inositol in pregnant women with glucose intolerance D Dell'Edera, F Sarlo, A Allegretti, F Simone, MG Lupo, AA Epifania Biomedical reports 7 (2), 169-172, 2017 | 29 | 2017 |
| PCSK9 promotes arterial medial calcification MG Lupo, A Bressan, M Donato, P Canzano, M Camera, P Poggio, ... Atherosclerosis 346, 86-97, 2022 | 28 | 2022 |
| PCSK9 affects astrocyte cholesterol metabolism and reduces neuron cholesterol supplying in vitro: potential implications in Alzheimer’s disease B Papotti, MP Adorni, C Marchi, F Zimetti, N Ronda, G Panighel, MG Lupo, ... International journal of molecular sciences 23 (20), 12192, 2022 | 24 | 2022 |
| Differential effects of red yeast rice, Berberis aristata and Morus alba extracts on PCSK9 and LDL uptake MG Lupo, C Macchi, S Marchianò, R Cristofani, MF Greco, S Dall'Acqua, ... Nutrition, Metabolism and Cardiovascular Diseases 29 (11), 1245-1253, 2019 | 24 | 2019 |
| 16p11. 2 microdeletion syndrome: a case report D Dell’Edera, C Dilucca, A Allegretti, F Simone, MG Lupo, C Liccese, ... Journal of Medical Case Reports 12, 1-6, 2018 | 24 | 2018 |
| Peptide modulators of Rac1/Tiam1 protein‐protein interaction: an alternative approach for cardiovascular diseases A Contini, N Ferri, R Bucci, MG Lupo, E Erba, ML Gelmi, S Pellegrino Peptide Science 110 (5), e23089, 2018 | 24 | 2018 |
| PCSK9 levels are raised in chronic HCV patients with hepatocellular carcinoma S Fasolato, S Pigozzo, P Pontisso, P Angeli, M Ruscica, E Savarino, ... Journal of Clinical Medicine 9 (10), 3134, 2020 | 23 | 2020 |
| From lipoprotein apheresis to proprotein convertase subtilisin/kexin type 9 inhibitors: Impact on low-density lipoprotein cholesterol and C-reactive protein levels in … MG Zenti, A Altomari, MG Lupo, M Botta, E Bonora, A Corsini, M Ruscica, ... European Journal of Preventive Cardiology 25 (17), 1843-1851, 2018 | 23 | 2018 |
Massimiliano RuscicaUniversità degli Studi di Milanoยืนยันอีเมลแล้วที่ unimi.it